Ganciclovir(GCV)is an effective agent against ocular herpes simplex virus(HSV)and human cytomegalic inclusion disease virus(CMV)infection. The main obstacle to its ophthalmic dosage forms is its low ocular bioavailability, especially its poor vitreous availability. Intravitreal injection of GCV to treat retinitis in order to become a research focus at this stage.